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B cell responses are classifi  ed as T-dependent 
(T-D) or T-independent (T-I) based on the re-
quirement for T cell help in antibody produc-
tion (1). T-D antigens are proteins that are 
processed and presented on MHC class II mol-
ecules for recognition by cognate helper T 
cells. T-I antigens are divided into type I and 
type II. The former are mitogenic stimuli such 
as LPS, CpG, or poly-IC that elicit polyclonal 
B cell activation via Toll-like receptors, whereas 
the latter are polysaccharides that engage the B 
cell receptor and thus induce antigen-specifi  c 
B cell responses.
T-I type II antigens elicit robust and long-
lasting primary antibody responses in mice (2), 
and polysaccharide vaccines such as Pneumovax 
and Menomune confer long-term humoral 
protection in adult humans. However, T-I type 
II antigens do not elicit a recall response; i.e., a 
boost in antibody production upon secondary 
immunization (3–6). Nevertheless, splenocytes 
from mice immunized with T-I type II anti-
gens can respond to secondary challenge when 
adoptively transferred into naive irradiated re-
cipients, and injection of immune serum into 
naive recipients before adoptive transfer sup-
presses this response (3, 4).
T-D antigens elicit memory B cells, which 
develop in T-D germinal centers and can be 
identifi  ed by somatic mutations in their Ig loci 
or by surface expression of secondary Ig iso-
types (7, 8). T-I type II antigens stimulate ex-
trafollicular foci of plasma cell production (2) 
and short-lived presumably abortive T-I ger-
minal centers (9, 10). It is not known whether 
T-I type II immune responses generate mem-
ory B cells. Very low levels of somatic hyper-
mutation (11) and low frequency of switching 
to secondary Ig isotypes during T-I type II re-
sponses hinder the identifi  cation of T-I mem-
ory B cells using these criteria, and it is widely 
accepted that memory B cells are derived only 
from T-D responses (1, 7, 8, 12, 13). Here we 
show that T-I type II immune responses gener-
ate memory B cells whose secondary activation 
by polysaccharides is stringently regulated by 
antigen-specifi  c IgG antibodies.
RESULTS AND DISCUSSION
T-I type II immune responses generate 
memory B cells
Memory B cells are quiescent B cells derived 
from proliferating antigen-experienced pre-
cursors (14). We used an in vivo BrdU pulse-
chase strategy to test whether a model T-I type 
II antigen 4-hydroxy-3-nitrophenylacetyl 
(NP)-Ficoll elicits memory B cells. To ensure 
that the analysis was not confounded by BrdU 
incorporation into dividing bone marrow B 
cell precursors, we adoptively transferred allo-
type-marked (CD45.1+) splenic B cells from 
B1-8high IgH knock-in mice (15) into naive 
wild-type recipients before immunization and 
subsequently analyzed only the transferred 
population. Recipient mice were immunized 
with NP-Ficoll and fed BrdU for the duration 
of the proliferative phase of the T-I type II 
  response (days 1–5; reference 15), after which 
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BrdU was withdrawn. Incorporation of BrdU into dividing 
B cells was assessed by fl  ow cytometry immediately after 
BrdU withdrawal on day 5 after immunization. To detect 
quiescent long-term survivors derived from activated precur-
sors, BrdU retention was assayed on days 15, 60, and 120 
(Fig. 1 A). We detected allotype-marked BrdU-labeled B 
cells in the spleen of NP-Ficoll immunized recipients, but 
not in control recipients injected with PBS and fed BrdU 
(Fig. 1 B). BrdU-labeled B cells were Igλ+ (Fig. 1 B) and 
thus NP-specifi  c (15, 16). Because subsequent cell division 
in the absence of BrdU (days 5–120) would have resulted in 
loss of BrdU by dilution, the detected BrdU-labeled cells 
must be quiescent.
The BrdU pulse-chase strategy described above might 
have labeled long-lived terminally diff  erentiated plasma cells 
and/or quiescent memory B cells. To distinguish between 
these cell types, we analyzed BrdU-labeled cells for the ex-
pression of a plasma cell marker (Syndecan-1) and for anti-
body secretion. The majority of BrdU-labeled cells expressed 
B cell marker B220, although at lower levels than naive 
B cells, and were Syndecan-1− (Fig. 1 C). To verify that 
BrdU-labeled cells did not secrete antibodies, we purifi  ed 
Igλ+ B1-8high B cells by FACS on day 30 after adoptive 
transfer and NP-Ficoll immunization and tested them for 
antibody secretion by ELISPOT. They were indeed nonse-
cretory (not depicted). Consistent with the possibility that 
BrdU-labeled cells were memory B cells, 8% expressed a 
secondary Ig isotype (IgG3) on their surface (Fig. 1 C). We 
conclude that quiescent BrdU-labeled B220low Syndecan-1− 
cells derived from the immune response to NP-Ficoll are 
memory B cells.
Immune responses against polysaccharides do not require 
T cells for antibody production (1). To test T cell require-
ment for the development of memory B cells against polysac-
charides, we repeated the BrdU pulse-chase experiment 
described above in T cell–defi   cient mice. TCRβ−/−δ−/− 
mice were adoptively transferred with B1-8high B cells, im-
munized with NP-Ficoll or PBS, and fed BrdU (days 1–5). 
To ensure that the transferred B cell sample was not conta-
minated with T cells, we performed double depletion of 
CD90.2+ cells and confi  rmed the purity of the sample by 
CD3 staining (not depicted). BrdU-labeled Igλ+ B1-8high 
memory B cells were detected in TCRβ−/−δ−/− recipients 
on day 15 after NP-Ficoll immunization (Fig. 1 D). Thus, 
memory B cell development in response to polysaccharide 
immunization is T cell–independent.
Figure 1.  T-I type II immune response generates memory B cells. 
(A) BrdU pulse-chase strategy. (B) BrdU staining of adoptively transferred 
B1-8high B cells (top) and Igλ staining of BrdU-gated B1-8high B cells (bot-
tom) from NP-Ficoll–immunized or naive wild-type recipients analyzed at 
the indicated time points. (C) B220 versus Syndecan-1 (top) and B220 
versus IgG3 (bottom) staining of B1-8high B cells from naive recipients on 
day 15 after adoptive transfer (left) and of BrdU-gated B1-8high B cells 
from NP-Ficoll–immunized recipients on day 15 after adoptive transfer 
and immunization (right). (D) BrdU staining of adoptively transferred 
B1-8high B cells (top) and Igλ staining of BrdU-gated B1-8high B cells (bot-
tom) from NP-Ficoll–immunized or naive TCRβ−/−δ−/− recipients analyzed 
at the indicated time points. (E) BrdU staining of adoptively transferred 
B1-8high B cells (top) and Igλ staining of BrdU-gated B1-8high B cells (bottom) 
from wild-type recipients immunized with NP-coupled (NP-Strep) or 
noncoupled (Strep) S. pneumoniae and analyzed at the indicated time 
points. All data are representative of two to four independent experi-
ments with two to three mice per time point.JEM VOL. 203, February 20, 2006  307 
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Pathogens that induce T-I type II responses include 
bacteria such as Streptococcus pneumoniae. We tested whether, 
similar to NP-Ficoll, epitopes carried on the bacterial cell 
surface elicit memory B cells. Mice were adoptively trans-
ferred with B1-8high B cells, immunized with NP-coupled 
or noncoupled S. pneumoniae, and fed BrdU (days 1–5). 
The immune response against NP–S. pneumoniae, but not 
against noncoupled bacteria, generated NP-specifi  c (Igλ+) 
memory B cells detected by BrdU staining on day 15 after 
immunization (Fig. 1 E). Therefore, pathogens that induce 
T-I type II immune responses stimulate production of 
memory B cells.
T-I memory B cells resemble naive B cells in their life span 
and sensitivity to polysaccharide antigens
Naive B cells and T-D memory B cells are long-lived (17–
19). To estimate the life span of T-I memory B cells, we 
compared their survival to that of naive B cells. Adoptively 
transferred naive Igλ+ B1-8high B cells initially constituted 
0.27% of total splenocytes, and in the absence of immuniza-
tion their number declined gradually, reaching half of the 
initial input in  90 d (Fig. 2 A). NP-Ficoll immunization 
resulted in 10-fold expansion of this population by day 5, fol-
lowed by a sharp decline from 2.7 to 0.7% of total spleno-
cytes between days 5–30 (Fig. 2 A). This loss of Igλ+ B1-8high 
B cells in immunized recipients was disproportionate to the 
loss of Igλ+ B1-8high B cells in naive recipients during the 
same time period (from 0.27 to 0.22%). After day 30, how-
ever, the half-life of the Igλ+ B1-8high B cell population was 
equivalent in immunized and naive recipients. Notably, Igλ+ 
B1-8high B cells remained more numerous in immunized than 
in naive recipients for up to 4 mo. These results indicate that 
after the initial expansion and loss of B cells responding to 
T-I type II antigens, an expanded long-lived population of 
memory B cells is maintained with a half-life similar to that 
of naive B cells.
Next, we compared the sensitivity of naive and T-I mem-
ory B cells to various doses of a polysaccharide antigen. B cells 
from naive or NP-Ficoll–primed B1-8high IgH knock-in mice 
expressing CD45.1 allotype were purifi   ed, labeled with 
CFSE, and adoptively transferred into wild-type recipients. 
NP-Ficoll priming was performed 30 d before adoptive trans-
fer. The proliferative response of transferred B1-8high B cells 
was assessed by CFSE dilution on day 5 after NP-Ficoll im-
munization of recipients. We found no diff  erence between 
naive and primed Igλ+ B1-8high B cells in their responsiveness 
to doses of NP-Ficoll ranging from 1 to 50 μg (Fig. 2 B). 
This suggests that naive and T-I memory B cells of the same 
affi   nity have similar sensitivity to polysaccharide antigens.
T-I memory B cells differ from T-D memory B cells by cell 
surface marker phenotype
To determine whether there are phenotypic diff  erences be-
tween T-I and T-D memory B cells, we examined their cell 
surface marker phenotype. B1-8high B cells were adoptively 
transferred into wild-type recipients, which were then im-
munized either with NP-Ficoll or with a T-D antigen NP–
chicken γ globulin (NP-CGG). Igλ+ B1-8high B cells derived 
from T-I or T-D responses diff  ered in the pattern of CD21 
versus CD23 expression: the former expressed low levels of 
CD21 and CD23, whereas the latter resembled follicular 
(CD21low CD23high) and marginal zone (CD21high CD23low) 
B cells (Fig. 3 A).
To determine whether such phenotypic diff  erences are 
found in naturally generated memory B cell populations of 
T-I or T-D origin, we analyzed the phenotype of memory 
B cells identifi  ed by surface expression of IgG1+IgG3 in 
TCRβ−/−δ−/−, PKCβ−/−, and wild-type mice. IgG+ mem-
ory B cells in TCRβ−/−δ−/− mice, which can produce only 
T-I responses, showed the pattern of CD21 versus CD23 
  expression similar to that of Igλ+ B1-8high memory B cells 
derived from NP-Ficoll immunization (Fig. 3, A and B). 
In contrast, PKCβ−/− mice, which can produce only T-D 
responses (20), accumulated IgG+ memory B cells resem-
bling Igλ+ B1-8high memory B cells derived from NP-CGG 
immunization (Fig. 3, A and B). Finally, in wild-type mice, 
IgG+ B cells with T-I memory phenotype (CD21low 
CD23low) constituted  50% of the total IgG+ memory B cell 
pool (Fig. 3 B). These results indicate that naturally aris-
ing T-I memory B cells show the same surface phe-
notype as Igλ+ B1-8high memory B cells that develop in 
response to NP-Ficoll immunization. Furthermore, T-I 
memory B cells are phenotypically distinct from conven-
tional T-D memory B cells and comprise a signifi  cant   portion 
of the total IgG+ memory B cell pool.
Figure 2.  T-I memory B cells resemble naive B cells in their life 
span and sensitivity to polysaccharide antigens. (A) Survival of adop-
tively transferred Igλ+ B1-8high B cells in NP-Ficoll–immunized and naive 
wild-type recipients. The number of Igλ+ B1-8high B cells per total spleno-
cytes is plotted against the time after adoptive transfer. Average values 
for each time point are plotted as bars. (B) CFSE dilution by adoptively 
transferred naive and NP-Ficoll–primed Igλ+ B1-8high B cells on day 5 
after NP-Ficoll immunization. Doses of NP-Ficoll used for immunization 
are indicated.308  B CELL MEMORY TO T-INDEPENDENT TYPE II ANTIGENS | Nussenzweig et al. 
Secondary activation of T-I memory B cells is regulated 
by antigen-specifi  c IgG antibodies
Next, we tested whether T-I memory B cells respond to sec-
ondary challenge with a polysaccharide antigen. To generate 
and label T-I memory B cells, wild-type mice were adop-
tively transferred with allotype-marked (CD45.1+) B1-8high 
B cells, immunized with NP-Ficoll, and fed BrdU (days 1–5). 
On day 20 after primary immunization, splenocytes were 
transferred into a second group of naive wild-type recipients 
and challenged with PBS or NP-Ficoll (Fig. 4 A). Alterna-
tively, BrdU-labeled memory B cells were rechallenged with 
PBS or NP-Ficoll without adoptive transfer (Fig. 4 C). By 
day 5 after secondary challenge with NP-Ficoll, but not with 
PBS, BrdU-labeled memory B cells that had been adoptively 
transferred into naive recipients lost BrdU due to their pro-
liferation leading to BrdU dilution (Fig. 4 B). In contrast, 
BrdU-labeled memory B cells that had not been adoptively 
transferred into naive recipients retained BrdU (Fig. 4 D), 
thus not responding to secondary challenge with NP-  Ficoll. 
Remarkably, this inhibition of memory B cell proliferation in 
response to secondary NP-Ficoll challenge was not observed 
in activation-induced cytidine deaminase (AID)−/− mice 
(Fig. 4 D) defi  cient in class switch recombination (21). These 
results indicate that T-I memory B cells are responsive to 
secondary challenge with polysaccharide antigens; however, 
their reactivation is suppressed in primed wild-type mice, but 
not in AID-defi  cient or naive mice.
To determine whether the absence of antigen-specifi  c 
IgG antibodies accounts for the lack of suppression of the T-I 
memory B cell response, we tested the recall response to NP-
Ficoll in AID−/− and wild-type mice. Secondary immuniza-
tion boosted NP-specifi  c IgM titers in AID-defi  cient but not 
in wild-type mice (Fig. 4 E). Next, we injected AID−/− mice 
with NP-specifi  c IgG antibody, isotype control antibody, or 
PBS 1 d before secondary NP-Ficoll immunization. NP-
specifi  c but not isotype control antibody suppressed the recall 
response to NP-Ficoll in AID−/− mice (Fig. 4 F). To deter-
mine whether IgG-mediated suppression of the T-I type II 
recall response depends on the inhibitory Fc receptor 
FcγRIIB (22), we tested the recall response to NP-Ficoll in 
FcγRIIB−/− mice. Secondary NP-Ficoll immunization did 
not boost NP-specifi  c antibody titers in FcγRIIB−/− mice 
(not depicted). We conclude that antigen-specifi  c IgG anti-
bodies regulate memory B cell responses against polysacchar-
ides via an FcγRIIB-independent mechanism.
We have uncovered an expanded and long-lived popula-
tion of memory B cells elicited by polysaccharides and bacte-
ria in the absence of T cell help, which diff  er from conventional 
T-D memory B cells in their cell surface phenotype   (CD21low 
CD23low). Although more numerous than the original naive 
antigen-specifi  c B cell pool, T-I memory B cells have a simi-
lar life span and sensitivity to limiting doses of polysaccharide 
antigens compared with naive B cells of the same affi   nity. 
Therefore, a distinct characteristic of T-I memory is increased 
quantity rather than quality of antigen-specifi  c clones, con-
forming to Burnet’s postulate that clonal expansion accounts 
for immunologic memory (23).
Our data indicate that secondary activation of T-I mem-
ory B cells is stringently regulated by antigen-specifi  c IgG 
antibodies. This regulation is reminiscent of the inhibition of 
primary humoral responses by passively transferred immune 
serum, fi  rst described by Emil von Behring. This phenome-
non is limited to T-I type II and particulate antigens, such as 
sheep red blood cells (24). It is effi   ciently mediated by pas-
sively transferred antigen-specifi  c IgG antibodies of all iso-
types (25) but does not depend on the inhibitory Fc receptor 
FcγRIIB (26). However, the physiologic relevance of regu-
lation of primary B cell responses by passively transferred 
  immune serum was uncertain because antigen-specifi  c 
  antibodies normally appear only after a productive B cell 
response. Our fi  ndings reveal a physiologic function for 
IgG-mediated suppression in regulating memory B cell re-
sponses to T-I type II antigens.
Because of their poor biodegradability, T-I type II  anti-
gens, including synthetic and native bacterial polysaccharides, 
are retained in the organism for long periods (27). The exis-
tence of an expanded and long-lived pool of memory B cells 
capable of responding to such persistent antigens necessitates 
a suppressive mechanism to prevent their continuous reacti-
vation leading to antibody overproduction. Antigen-specifi  c 
Figure 3.  T-I memory B cells are phenotypically distinct from T-D 
memory B cells. (A) CD21 versus CD23 staining of adoptively transferred 
Igλ+ B1-8high B cells before and after immunization with NP-Ficoll on day 
15 (top) or with NP-CGG on day 25 (bottom). (B) B220 versus IgG1+IgG3 
staining of splenocytes depleted of CD43+ and IgM+ cells (top) and  
CD21 versus CD23 staining of IgG1+IgG3-gated B cells (bottom). Mouse 
strains are indicated. Splenocytes from AID−/− mice, defi  cient in class 
switch recombination (reference 21), were used as a negative control for 
anti-IgG staining.JEM VOL. 203, February 20, 2006  309 
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IgG, a product of the immune response, serves this important 
negative feedback regulation, thereby maintaining humoral 
homeostasis. In fact, humans who are unable to produce IgG 
because of CD40L or AID defi  ciency suff  er from hyper-IgM 
syndromes (HIGM1 and HIGM2; references 28 and 29).
T-I type II responses have long been thought to lack 
memory B cell production, which has hindered the eff  ort 
to develop T-I vaccination strategies. Very few polysac-
charide vaccines are currently available in which native 
bacterial polysaccharide capsule antigens are used. Yet, 
our data demonstrate the existence of T-I memory B cells 
and stringent regulation of their secondary activation by 
IgG antibodies specifi  c to the immunizing antigen. These 
fi  ndings contribute to our understanding of the mode of 
action of the existing polysaccharide vaccines and argue in 
favor of a wider application of polysaccharide-based strate-
gies in vaccination.
MATERIALS AND METHODS
Animals and procedures. C57BL/6 and TCRβ−/−δ−/− mice were pur-
chased from The Jackson Laboratory. B1-8high IgH knock-in mice were 
generated previously (15). AID−/− mice were provided by T. Honjo (Kyoto 
University, Kyoto, Japan), PKCβ−/− mice by A. Tarakhovsky (The Rock-
efeller University, New York, NY), and FcγRIIB−/− mice by J. Ravetch 
(The Rockefeller University, New York, NY). All knock-in and knockout 
strains were on a C57BL/6 background. Mouse procedures were performed 
under The Rockefeller University’s Institutional and Animal Care Use 
Committee–approved protocols.
Splenic B cells were purifi  ed by negative selection with anti-CD43 
MACS beads (Miltenyi Biotec). When indicated, an additional round of 
negative selection was performed with anti-CD90.2 MACS beads. Approxi-
mately 2 × 107 purifi  ed B cells per recipient mouse were injected i.v. 1 d 
before immunization. CFSE labeling was performed by incubating B cells 
(107 cells/ml) in PBS containing 5 μg/ml CFDASE dye for 10 min at 37°C 
with subsequent PBS washes.
Mice were immunized i.p. with 50 μg NP190-Ficoll (Biosearchtech) in 
PBS or with 50 μg NP16-CGG (Biosearchtech) in Imject Alum (Pierce 
Chemical Co.). S. pneumoniae cells (nonlytical Lyt4-4 variant of the strain 
R36A; provided by A. Tomasz, The Rockefeller University, New York, NY ) 
were grown in C+Y medium (30) until they reached an OD of 0.7 corre-
sponding to a density of 108 cells per ml. Bacterial cells were pelleted by cen-
trifugation and incubated for 5 min with 0.5 mg/ml NP-OSu   (Biosearchtech). 
The conjugation reaction was quenched with 1.2 mg/ml glycylglycine in 
PBS, and the bacteria were washed twice with PBS. Mice were injected i.p. 
with 108 S. pneumoniae or NP-coupled S. pneumoniae cells. In BrdU pulse-
chase experiments, mice were fed BrdU in the drinking water at a concen-
tration of 0.5 mg/ml on days 1–5 after immunization.
The 9T13 hybridoma cell line, provided by T. Azuma (Tokyo Univer-
sity of Science, Noda, Chiba, Japan), was the source of anti-NP IgG1 anti-
body. 9T13 antibody was purifi  ed from hybridoma supernatants by protein 
G–Sepharose beads (GE Healthcare) and dialyzed overnight against PBS. 
Figure 4.  Antigen-specifi  c IgG suppresses T-I memory B cell 
response. (A and C) Strategies for BrdU labeling and secondary 
challenge of T-I memory B cells. (B) BrdU staining of Igλ+ B1-8high 
memory B cells, generated by NP-Ficoll immunization in the presence 
of BrdU, after adoptive transfer into naive recipients and secondary 
challenge with PBS or NP-Ficoll. (D) BrdU staining of B1-8high (top) or 
AID−/−B1-8high (bottom) B cells adoptively transferred into wild-type 
or AID−/− recipients, respectively, which were primed with NP-Ficoll 
in the presence of BrdU and rechallenged with PBS or NP-Ficoll. 
(E) NP-specifi  c IgM titers versus time after primary and secondary 
NP-Ficoll immunization of AID−/− and wild-type mice. Arrows indicate 
time of immunization. Average values are plotted as bars. Data are 
representative of three independent experiments with four to fi  ve 
mice per group. (F) NP-specifi  c IgM titers on day 5 after secondary 
NP-Ficoll immunization of AID−/− mice, preinjected with NP-specifi  c 
IgG1, isotype control antibody, or PBS. All mice were primed with 
NP-Ficoll 1 mo before secondary immunization. Background IgM titer 
values (before secondary immunization) were subtracted. Average 
values are plotted as bars. Data are representative of two independent 
experiments with four to fi  ve mice per group.310  B CELL MEMORY TO T-INDEPENDENT TYPE II ANTIGENS | Nussenzweig et al. 
Isotype control antibody (13C4) was purchased from the Rockefeller 
  Monoclonal Antibody facility. 0.4 mg of each antibody was injected i.v. 1 d 
before secondary NP-Ficoll immunization.
ELISA. NP-specifi  c antibody titers were measured by sandwich ELISA. 
High-binding plates (Costar) were coated overnight with 5 μg/ml NP2-BSA 
(Biosearchtech), blocked for 1 h with PBS containing 0.2% Tween-20 and 
1% BSA, and incubated with serial serum dilutions for 2 h, followed by a 2-h 
incubation with horseradish peroxidase–conjugated anti–mouse IgM (Jack-
son ImmunoResearch Laboratories). ELISA plates were developed using 
1-Step ABTS (Pierce Chemical Co.). Immune serum from the same mouse 
was included in all plates, and titers were expressed in arbitrary units relative 
to that standard.
FACS analysis and BrdU detection. The following antibodies to murine 
epitopes were used for FACS staining analysis: CD21-FITC, CD23-PE, 
B220-PE or APC, Syndecan-1-PE, Igλ-biotin, IgG1-biotin, IgG3-biotin, 
and CD45.1-APC (BD Biosciences). Streptavidin-conjugated PerCP (BD 
Biosciences) was used as a secondary reagent for biotinylated antibodies. 
  Before staining of rare IgG1
+ and IgG3
+ B cells, splenocytes were depleted 
by anti-CD43 and anti-IgM MACS beads (Miltenyi Biotec). BrdU was 
  detected using a BrdU-FITC Flow kit (BD Biosciences).
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